News Releases - Achieve Life Sciences
HOME
ABOUT ACHIEVE
About Achieve
Management Team
Board of Directors
PRODUCTS
Cytisinicline
NEWS
Press Releases
Events
Blog
INVESTORS
CONTACT
HOME
ABOUT ACHIEVE
About Achieve
Senior Management
PRODUCTS
Cytisinicline
NEWS
INVESTORS
CONTACT
News Releases
Home
/
News Releases
Home
ivps4
2017-06-16T21:39:52+00:00
Investors Home
Corporate Governance
News Releases
Financial Information
SEC Filings
Events and Webcasts
Investor Contacts
Investor Alerts
NASDAQ: ACHV
NASDAQ: OGXI
News Releases
Investor Alerts
Year
All Years
2021
2020
2019
2018
2017
Keywords
Go
Advanced Search
Search
Search Headlines Only
From
To
Asset Types
Photos
Video
Audio
Documents
Events
Standard
Apr 22, 2021
Achieve Life Sciences, Inc. to Host Virtual Non-Deal Roadshow on Tuesday, April 27, 2021
Apr 14, 2021
Achieve Announces Publication of the ORCA-1 Phase 2b Clinical Trial of Cytisinicline in Adult Smokers in
Nicotine and Tobacco Research
Mar 25, 2021
Achieve Announces Publication of the RAUORA Head-to-Head Non-Inferiority Clinical Trial Comparing Cytisinicline and Chantix® (varenicline) in
Addiction
Mar 16, 2021
Achieve Life Sciences to Participate in M-Vest and Maxim Group Inaugural Emerging Growth Virtual Conference
Mar 15, 2021
Achieve Life Sciences Announces Appointment of Dr. Bridget Martell and Dr. Cindy Jacobs to Board of Directors
Show
5
10
25
50
100
per page
«
1
2
3
4
5
6
7
8
9
…
22
»
NASDAQ: ACHV
NASDAQ: OGXI
1dy
1mo
6mo
1yr
5yr
Stock Info
NASDAQ: ACHV
NASDAQ: OGXI
Go to Top
